mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial

Sjoukje F. Oosting, Astrid A.M. van der Veldt*, Corine H. GeurtsvanKessel, Rudolf S.N. Fehrmann, Rob S. van Binnendijk, Anne Marie C. Dingemans, Egbert F. Smit, T. Jeroen N. Hiltermann, Gerco den Hartog, Mathilda Jalving, Tatjana T. Westphal, Arkajyoti Bhattacharya, Marieke van der Heiden, Guus F. Rimmelzwaan, Pia Kvistborg, Christian U. Blank, Marion P.G. Koopmans, Anke L.W. Huckriede, Cecile A.C.M. van Els, Nynke Y. RotsDebbie van Baarle, John B.A.G. Haanen, Elisabeth G.E. de Vries

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

57 Citations (Scopus)

Fingerprint

Dive into the research topics of 'mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology